AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
49 hedge funds and large institutions have $22.5M invested in AVEO Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 11 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
78% more capital invested
Capital invested by funds: $12.6M → $22.5M (+$9.84M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 51 → 49 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $116K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$656K |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$649K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$281K |
| 4 |
SIM
Spark Investment Management
New York
|
+$160K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$145K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$886K |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$562K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$61K |
| 4 |
Millennium Management
New York
|
-$55K |
| 5 |
TI
Telemetry Investments
New York
|
-$37K |
AVEO Hedge Fund Activity: Q1 2015 in Review
49 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2015, worth a combined $22.5M — up 78% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AVEO and 9 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 17 added.
The largest buyer was Renaissance Technologies, adding an estimated $656K. The largest seller was D.E. Shaw & Co, cutting an estimated $886K.
- 49 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2015, down from 51 in Q4 2014.
- Funds reported $22.5M of AVEO Pharmaceuticals, Inc. stock for Q1 2015, up 78% quarter-over-quarter.
- 9 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2015 and 11 closed out, a net change of -2 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2015 was Renaissance Technologies, an estimated $656K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q1 2015 was D.E. Shaw & Co, an estimated $886K sold.
Based on aggregated 13F filings for Q1 2015.